A Study of Ixekizumab in Participants With Active Psoriatic Arthritis

Clinical trial NCT01695239 · COMPLETED

Trial details

NCT number: NCT01695239
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriasis, Arthritic

Start date: 2012-12-01
Primary completion: 2014-12-01
Enrollment: 417

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.